Biotech Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Coagulation
Research on coagulation discussed by S. Morgera and co-researchers
July 13th, 2009
"Citrate anticoagulation is an excellent alternative to heparin anticoagulation for critically ill patients requiring continuous renal replacement therapy. In this article, we provide a safe and an easy-to-handle citrate anticoagulation protocol with variable treatment doses and excellent control of the acid-base status," researchers in Berlin, Germany report. "Prospective observational study. University hospital. One hundred sixty-two patients with acute renal failure requiring renal replacement therapy were enrolled in the study. A continuous venovenous hemodialysis-based citrate anticoagulation protocol using a 4% trisodium solution, a specially designed dialysate...
Source: Biotech Business Week (2009-07-13)
|
